HOUSTON, March 29, 2018 -- Kayne Anderson MLP Investment Company (the “Company”) (NYSE:KYN) announced today its quarterly distribution of $0.45 per share for the quarter ended February 28, 2018. The distribution will be payable on April 20, 2018 to common stockholders of record on April 13, 2018, with an ex-dividend date of April 12, 2018.
The Company estimates that 100% of this distribution will be treated as a return of capital for tax purposes. This estimate is based on the Company’s anticipated earnings and profits for fiscal 2018 and its accumulated earnings and profits as of November 30, 2017. The Company’s estimate does not include a projection of gains and losses on the sale of securities for the remainder of fiscal 2018. The final determination of the tax character of the distribution will be made in early 2019 when the Company can determine its actual earnings and profits for the full year (including gains and losses on sales of securities during fiscal 2018) and may differ substantially from this preliminary information.
Kayne Anderson MLP Investment Company is a non-diversified, closed-end management investment company registered under the Investment Company Act of 1940, whose common stock is traded on the NYSE. The Company's investment objective is to obtain a high after-tax total return by investing at least 85% of its total assets in energy-related partnerships and their affiliates (collectively, “MLPs”), and in other companies that, as their principal business, operate assets used in the gathering, transporting, processing, storing, refining, distributing, mining or marketing of natural gas, natural gas liquids, crude oil, refined petroleum products or coal.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains "forward- looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ from the Company’s historical experience and its present expectations or projections indicated in any forward-looking statements. These risks include, but are not limited to, changes in economic and political conditions; regulatory and legal changes; MLP industry risk; leverage risk; valuation risk; interest rate risk; tax risk; and other risks discussed in the Company’s filings with the SEC. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Company’s investment objective will be attained.
Contact:
KA Fund Advisors, LLC
877-657-3863
http://www.kaynefunds.com/


Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 



